From the Department of Pathology and Laboratory Medicine and
From the Department of Pathology and Laboratory Medicine and.
J Biol Chem. 2018 Aug 24;293(34):13349-13350. doi: 10.1074/jbc.H118.004818.
Mice harboring a particular allele of the human brain-derived neurotropic factor (BDNF mice) develop extreme obesity and insulin resistance when fed a high-fat diet. The underlying mechanisms of this genetic risk factor for obesity are unclear. In the current issue of JBC, Yang report that pharmacological inhibition of integral membrane protein CD36 significantly reduces body weight gain and improves glucose tolerance in BDNF mice. Targeting CD36 may therefore be a promising strategy to improve metabolic dysfunctions and normalize risk factors in obese individuals.
当喂食高脂肪饮食时,携带人类脑源性神经营养因子(BDNF)特定等位基因的小鼠会发展出极度肥胖和胰岛素抵抗。这种肥胖遗传风险因素的潜在机制尚不清楚。在本期 JBC 中,Yang 报告称,整膜蛋白 CD36 的药理学抑制可显著减少 BDNF 小鼠的体重增加并改善葡萄糖耐量。因此,靶向 CD36 可能是改善代谢功能障碍和使肥胖个体的危险因素正常化的有前途的策略。